Want to track OVID and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ovid Therapeutics Inc. (OVID) Statistics
Valuation metrics
Market Cap 332.35M
Enterprise value 229.19M
Trailing P/E (ttm) -7.05
Forward P/E -5.84
PEG ratio 0.13
Price/Sales (ttm) 45.18
Price/Book (mrq) 0.91
Enterprise Value/Revenue 32.18
Enterprise Value/EBITDA -9.55
Overview
Shares outstanding 130.18M
Float 113.96M
Shares short 8.53M
% Held by insiders 0.08%
% Held by institutions 0.37%
Average volume (10 days) 940.74K
Average volume (90 days) 2.41M
Price summary
52-Week low 0.41
52-Week high 3.1
Beta 0.18
50-Day moving average 2.42
200-Day moving average 2.14
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -3.39%
Operating margin -6.7%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.23%
Income Statement
Revenue (ttm) 7.25M
Revenue per share (ttm) 0.1
Quarterly revenue growth (yoy) 8.45%
Gross profit (ttm) 7.25M
EBITDA -42.17M
Net income to common (ttm) -17.14M
Diluted EPS (ttm) -0.33
Quarterly earnings growth (yoy) 8.45%
Balance Sheet
Total cash (mrq) 69.64M
Total cash per share (mrq) 2.11
Total debt (mrq) 13.42M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 10.17%
Book value per share (mrq) 2.69
Cash Flow
Cash flow statement -38.33M
Levered free cash flow (LFCF) -25.64M
